The emerging cannabis space was, for a time, the image of an investing success story, complete with high valuations and even higher expectations.
Now, post-bubble-burst, analysts have said as the stronger players begin solidifying their place in the industry, a new reality of consolidation and possible bankruptcies could drastically change, and narrow, the layout of the market.
“Consolidation is going to be a very big theme, likely, in 2020,” said David Kideckel, an analyst with AltaCorp Capital, in an interview with the Investing News Network (INN).
Kideckel added that a number of companies have missed not only analyst estimates but internal estimates as well and some are quickly burning through their reserves of cash.
This could mean what were once highly valued companies can now be purchased at a healthy discount by firms hunting for deals.
This valuation drop has already begun to affect merger deals in the US, Kideckel told INN, since valuations are significantly lower than what they were just earlier this year.
The deal — once called the “largest-ever public company acquisition” by Cresco Labs — is now moving forward with a non-brokered financing from Origin House to “strengthen the balance sheet of the combined company,” Cresco Labs said.
While the deal faced federal scrutiny from US regulators, the term adjustment served as a signal for the changing landscape in the industry.
Access to capital has deteriorated for marijuana firms
A part of this struggle has been a lack of capital. During a recent webinar event, Charles Taerk, president and CEO of Faircourt Asset Management, said, “The credit facilities and the equity markets have dried up.” This puts smaller cannabis players in a difficult situation.
Fundamental Research cannabis analyst Colin Tang said to INN in an email that another key factor in the ongoing slump in the industry has been the pricing pressure for product.
Since cannabis is a commodity, firms with little to no control of their cost base are at risk of being wiped out, said Tang, a phenomenon that could impact the smaller cannabis companies in Canada the hardest.
“As the Canadian cannabis industry matures, investors should expect a material decline in the number of small-scale cannabis producers,” Tang said.
Some experts say that the downward trend in value for the cannabis space isn’t finished falling just yet.
“In terms of thinking about this as a market correction, I don’t think we’re close to the bottom,” said Craig Behnke, an equity research analyst at MJBizDaily’s Investor Intelligence. He said this was mainly because the rush of euphoria that defined the early days of the industry hasn’t been completely wrung out from the markets.
Behnke said he wouldn’t be surprised if the current difficulties facing the industry caused some players to be eliminated.
The Canadian marijuana stock universe has faced a sharp decline in value for 2019, as indicated by the Canadian index tracking leading stocks in the market.
Consolidation will continue to play a part in the entire cannabis space
When it comes to the next steps for mergers and acquisitions, it’s a question of which cannabis companies have good assets but an unsustainable capital structure, Mike Regan, a fellow analyst with Investor Intelligence, said.
Regan is also expecting for the current challenges currently seen in the space to not only result in cheap acquisitions and takeovers, but complete industry departures as certain companies get absorbed by others.
“I think you’ll start to see more consolidation and separation as some of the stronger players combine and some of the weaker ones go away,” Regan said.
Behnke said he expects to see companies reduce growth plans and investment targets moving into 2020 that could lead to a rapid shrinking of the sector. “I would suspect that we continue to see more companies either reducing their guidance, perhaps even running out of cash, maybe even a bankruptcy or two,” Behnke said.
Investors have already noticed a variety of Canadian leaders lowering previously shared revenue guidance numbers in the back half of 2019.
Similarly, in the American cannabis market, Behnke expects to see companies that are nearing bankruptcy get scooped up by larger firms at a discount.
From the analyst’s perspective, a wide industry reduction could solve some of the problems currently facing cannabis, namely overcapacity.
According to Behnke’s calculation, over 2 million kilograms of cannabis could be produced annually by the top 11 licensed producers in Canada, while demand currently requires less than 1 million kilograms. A smaller sector could help bridge that gap, he said.
Behnke, like Regan, believes that a shrinking sector, while indicative of an overestimation of durability, could also breathe new life into the cannabis space.
“I do think that some capacity needs to go away,” Behnke continued, “but I also think that there are certain companies that are well run, have great products — they just ran out of capital or time to execute their business plan and somebody will step in and realize that there is a valuable asset there.”
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.
The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.
Mergers and acquisitions (M&A) in cannabis space have helped boost the industry to new levels.
Strategic sale of non-core assets by Lobe adds non-dilutive capital and shareholder value
Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce, further to its press release dated February 23, 2021, that it has completed the sale to Ionic Brands Corp. (“Ionic Brands”) of Lobe’s non-core cannabis assets relating to Washington-based Cowlitz County Cannabis Cultivation Inc. (“Cowlitz”) held by Lobe’s subsidiary vendor, Green Star Biosciences Inc. (the “Transaction”).
Seattle Area Grocery Chain Metropolitan Market to Begin Carrying KOIOS and Fit Soda on March 22, 2021
Adding to its existing presence on the west coast of the United States, all five KOIOS™ flavours and all four Fit Soda™ flavours will be carried in Metropolitan Market stores beginning on Monday, March 22, 2021. Serving the Seattle-Tacoma area (population 3.87 million), Metropolitan Market is one of five chains under its parent firm Good Food Holdings, which has a total of 51 stores in California, Oregon, and Washington State.
Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that beginning on Monday, March 22, 2021, Koios’ entire line of canned beverage products will be sold at all locations of Metropolitan Market, an urban format supermarket chain in the Seattle-Tacoma area of Washington State. In Q1 2021, the Company announced multiple placements of its beverage products with regional grocers in markets on the west coast of the United States including Market of Choice in Oregon Jensen’s in Southern California and major natural grocery chain Sprouts Farmers Market which has a substantial west coast presence with over one third of its locations (360+ stores across 23 states) in California as well as Washington State 1 . The Company has also recently announced other developments relating to its expansion efforts being undertaken in 2021 such as an in-house beverage canning facility and distribution agreements with regional and national wholesale partners.
Pineapple Express Delivery Partners with CannTrust to Offer Same-Day and Next-Day Delivery for estoraTM Medical Cannabis Patients in Ontario
Ensuring estoraTMpatients have seamless access to their high-quality medical cannabis products
World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announce that its subsidiary Pineapple Express Delivery Inc. (“Pineapple Express Delivery” or “PED”), a leading logistics technology company offering compliant and secure delivery of controlled substances and regulated products, has partnered with CannTrust Inc. to bring same-day and next-day delivery to estoraTM medical cannabis patients in Ontario
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.